Insights

Gathering insights about EnCore…

Similar companies to EnCore

EnCore Tech Stack

EnCore uses 8 technology products and services including AutoCAD, CATIA, Squarespace, and more. Explore EnCore's tech stack below.

AutoCAD
Cad & Graphics
CATIA
Cad & Graphics
Squarespace
Content Management System
Contao
Content Management System
Modernizr
Javascript Libraries
PHP
Programming Languages
FedEx
Transportation And Fleet Management
Adobe Fonts
Web Fonts

Media & News

Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
VANCOUVER, BC / ACCESS Newswire / February 12, 2026 / Verdera Energy Corp. (the "Company" or "Verdera") and POCML 7 Inc. (TSXV:POC.P) ("POCML7"), are pleased to announce that they have closed their previously announced offering of subscription receipts of Verdera and POCML7 for aggregate gross proceeds of $20 million (the "Offering"). Verdera has reserved the ticker symbol "V" on the TSX Venture Exchange (the "TSX-V") and expects trading on the TSX-V to commence on or about February 24, 2026.
Feb 12, 2026 | www.accessnewswire.com
Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026
Highlighting Optimized Once-Daily Weight-Based Dosing and Clinically Meaningful Fatigue Improvement San Diego, California--(Newsfile Corp. - January 23, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation thiol-based prodrugs for rare mitochondrial and pediatric diseases, today announced the presentation of interim data from its Phase 2 (EU) clinical study of TTI-0102 in patients with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) at Mitocon 2026 - a leading international conference dedicated to mitochondrial medicine being held in Pisa, Italy. The poster, titled "TTI-0102 in MELAS: PK/PD Results from a Phase 2 Study - Preliminary Evidence of Safety and Efficacy in Mitochondrial Disease," was presented on January 23 as part of Mitocon's Late-Breaking News session, a distinction reserved for data of high scientific and clinical relevance selected by the conference's Scientific Committee.
Jan 23, 2026 | www.newsfilecorp.com
Verdera Energy Announces $20 Million Qualifying Transaction Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SANTA FE, N.M., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Verdera Energy Corp. (the “Company” or “Verdera”) and POCML 7 Inc. (TSXV:POC.P) (“POCML7”), are pleased to provide an update in connection with the proposed transaction that will constitute a Qualifying Transaction of POCML7 under TSX Venture Exchange policies, as previously announced by Verdera on November 3, 2025 and November 26, 2025 (the “Proposed Transaction”).
Jan 07, 2026 | www.globenewswire.com
Contrasting MP Materials (NYSE:MP) and enCore Energy (NASDAQ:EU)
enCore Energy (NASDAQ: EU - Get Free Report) and MP Materials (NYSE: MP - Get Free Report) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership. Profitability This table compares enCore Energy and
Dec 26, 2025 | www.defenseworld.net
enCore Energy (NASDAQ:EU) Shares Up 14.3% – Still a Buy?
enCore Energy Corp. (NASDAQ: EU - Get Free Report) shares shot up 14.3% during trading on Friday. The stock traded as high as $2.69 and last traded at $2.6850. 1,112,040 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 3,033,760 shares. The stock had previously closed at $2.35.
Dec 21, 2025 | www.defenseworld.net
enCore Energy Appoints Wayne Heili to the Board of Directors; Announces the Retirement of Dr. Dennis Stover
NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Dec. 1, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the appointment of Mr. Wayne Heili to the Company's Board of Directors effective immediately.
Dec 01, 2025 | www.prnewswire.com
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite standard-of-care antihistamine treatment Dupixent, which inhibits IL-4 and IL-13, two key and central drivers of type 2 inflammation, is now approved for patients across seven chronic, inflammatory diseases in the EU TARRYTOWN, N.Y. and PARIS, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has approved Dupixent® (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in adult and adolescent patients 12 years and above with inadequate response to histamine-1 antihistamines (H1AH) and who are naïve to anti-immunoglobulin E (IgE) therapy for CSU.
Nov 25, 2025 | www.globenewswire.com

EnCore's Email Address Formats

EnCore uses at least 1 format(s):

EnCore Email Formats	Example	Percentage
First.Last@encoregroup.aero	John.Doe@encoregroup.aero	96%
First@encoregroup.aero	John@encoregroup.aero	2%
First.Middle@encoregroup.aero	John.Michael@encoregroup.aero	1%
FLast@encoregroup.aero	JDoe@encoregroup.aero	1%

Frequently Asked Questions

Where is EnCore's headquarters located?

EnCore's main headquarters is located at Huntington Beach, California United States. The company has employees across 1 continents, including North America.

What is EnCore's stock symbol?

EnCore is a publicly traded company; the company's stock symbol is EU.

What is EnCore's official website and social media links?

EnCore's official website is encoregroup.aero and has social profiles on LinkedIn.

What is EnCore's NAICS code?

EnCore's NAICS code is 3364 - Aerospace Product and Parts Manufacturing.

How many employees does EnCore have currently?

As of February 2026, EnCore has approximately 218 employees across 1 continents, including North America. Key team members include Chief Executive Officer: M. M.President Ceo Of Americhem Sales Corporation, Americhem Properties, Llc And Asc Performance Racing: A. W.President Ceo Of Americhem Sales Corporation, Americhem Properties, Llc And Asc Performance Racing: B. S.. Explore EnCore's employee directory with LeadIQ.

What industry does EnCore belong to?

EnCore operates in the Aviation and Aerospace Component Manufacturing industry.

What technology does EnCore use?

EnCore's tech stack includes AutoCADCATIASquarespaceContaoModernizrPHPFedExAdobe Fonts.

What is EnCore's email format?

EnCore's email format typically follows the pattern of First.Last@encoregroup.aero. Find more EnCore email formats with LeadIQ.

When was EnCore founded?

EnCore was founded in 2011.

EnCore

Q: What is EnCore's official website and social media links?

EnCore's official website is encoregroup.aero. EnCore has social profiles on LinkedIn.

Q: How many employees does EnCore have currently?

EnCore has approximately 218 employees.

Q: What technology does EnCore use?

EnCore's tech stack includes Lightbox, Microsoft Word, Microsoft, Webpack, Squarespace.

Aviation and Aerospace Component ManufacturingCalifornia, United States201-500 Employees

EnCore is a full floor-to-floor design, manufacturing, and certification company,  offering just about anything that passengers see on the interior of an aircraft- from galleys, lavatories, class dividers, closets, front row monuments, flooring and enhanced passenger experience products.